58TiP ASCENT-GYN-01 (GOG-3104/ENGOT-en26): A randomized, phase III study of sacituzumab govitecan (SG) vs treatment of physician’s choice (TPC) in patients (pts) with endometrial cancer (EC) after platinum-based chemotherapy and immunotherapy | Publicación